BioCity Nottingham, Pennyfoot Street, Nottingham, NG1 1GF
t: +44 (0) 115 8880 406f: +44 (0) 115 8229345

News Articles

Neurim wins the battle but not (yet) the war for innovators

14 September 2012

SCRIP Regulatory Affairs September 2012, 14-15
Authors: Mike Snodin and Michael Pears

This article appeared in the September 2012 edition of SCRIP Regulatory Affairs. It explains the positive aspects that the innovative pharmaceutical industry will find in the Neurim decision. However, it also highlights the difficulties in understanding how broadly (and to whom) the decision can be applied, as well as the challenges to be faced by national patent offices and courts in squaring the Neurim decision with the prior case law of the Court of Justice.

We have placed cookies on your device to help make this website better. You can click the link below to disable cookies, otherwise, we'll assume you're happy to continue
Close This Notice

Disable Cookies | 3rd Party Data Processors